INTRODUCTION {#omz024s1}
============

Synovial sarcoma is a malignant tumor, it accounts for approximately 5--10% of the soft tissue sarcoma, and mainly develops in the para-articular regions in adolescents and young adults \[[@omz024C1]\]. The combination of surgery and chemotherapy has resulted in about 60% 5-year survival rate and 50% 10-year survival rate, mainly because of the metastasis in lung \[[@omz024C2], [@omz024C3]\]. In the patients with synovial sarcoma, wide-resection surgery is usually performed for local recurrent control, while neo/adjuvant chemotherapy is commonly performed to decrease the risk of metastasis recurrences \[[@omz024C4]\]. We reported a case of synovial sarcoma extending into the vastus intermedius muscle beyond the intermuscular septum which is considered to be the greatest barrier to ensuring a safety margin in musculoskeletal surgery \[[@omz024C5]\].

CASE REPORT {#omz024s2}
===========

A 55-year-old female with a large mass was admitted to our hospital. She had no traumatic episode. Magnetic resonance imaging (MRI) revealed a well-defined and gadolinium-enhanced mass (5.5 × 4.9 cm) in her right thigh. MRI also revealed a mass extending into the vastus intermedius muscle beyond the intermuscular septum (red square and arrows in Figs [1](#omz024F1){ref-type="fig"} and [2](#omz024F2){ref-type="fig"}, and original schema in Fig. [3](#omz024F3){ref-type="fig"}). A needle biopsy from the mass confirmed the histological diagnosis of synovial sarcoma which was positive for SS-18 break apart by fluorescence in situ hybridization (FISH). After 2 cycles of neo-adjuvant chemotherapy, a wide resection of the tumor was performed. A histopathological examination (red square in Fig. [1](#omz024F1){ref-type="fig"}) showed that the tumor had direct invasion into the intermuscular septum (Fig. [4](#omz024F4){ref-type="fig"}). Five months after the surgery, the patient has shown no sign of recurrence.

![Preoperative sequential MRI clearly showed the intermuscular-septum line (red arrows) and direct tumoral invasion beyond the intermuscular septum (red square).](omz024f01){#omz024F1}

![Preoperative sequential MRI clearly showed the intermuscular-septum line (red arrows) and direct tumoral invasion beyond the intermuscular septum (red square).](omz024f02){#omz024F2}

![To facilitate the understanding of how the tumor extended beyond the intermuscular septum, we created the original schema, which revealed a mass extending into the vastus intermedius muscle beyond the intermuscular septum.](omz024f03){#omz024F3}

![A histopathological examination (red square in Fig. [1](#omz024F1){ref-type="fig"}) showed that the tumor had direct invasion into the intermuscular septum.](omz024f04){#omz024F4}

DISCUSSION {#omz024s3}
==========

The intermuscular septum is a robust fibrous connective tissue which divides muscular compartments of the thigh and it is considered to be the greatest barrier to ensuring a safety margin in musculoskeletal surgery and it is important to consider strength of the barriers to obtain a safe margin in sarcoma surgery \[[@omz024C5]\]. Preoperative sequential MRI in this case clearly showed the intermuscular-septum line (red arrows in Figs [1](#omz024F1){ref-type="fig"} and [@omz024C2]) and direct tumoral invasion beyond the intermuscular septum. A histopathological investigation (red square in Fig. [1](#omz024F1){ref-type="fig"}) showed the direct invasion to the intermuscular septum although synovial sarcoma should be an indolent tumor (Fig. [4](#omz024F4){ref-type="fig"}). Although some soft tissue sarcoma such as myxofibrosarcoma sometimes show direct invasion to these barriers \[[@omz024C6], [@omz024C7]\], synovial sarcoma seldom shows such direct invasive pattern to barriers, much less the greatest barrier like an intermuscular septum. Moreover, in the patients with synovial sarcoma, wide-margin surgery with even though thin barriers resulted in good local control rates. Although synovial sarcoma usually cannot show such a local invasive pattern, a relatively indolent tumor growth might allow for such unfamiliar development of a tumor, even against a robust barrier. To our knowledge, no previous study has reported such unique extension of a synovial sarcoma beyond the intermuscular septum. We believe that these radiological and pathological findings have a huge impact to sarcoma surgeons. Surgeons should be aware of the potential vulnerability of the intermuscular septum. A careful preoperative examination is warranted to obtain a safe margin in sarcoma surgery.
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